Catarina Romaozinho
Overview
Explore the profile of Catarina Romaozinho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva A, Marques M, Rodrigues L, Santos L, Romaozinho C, Caramelo F, et al.
Ren Fail
. 2025 Jan;
47(1):2447791.
PMID: 39801455
No abstract available.
2.
Correia A, Silva A, Mira F, Pinto R, Ferreira E, Marques M, et al.
Hemodial Int
. 2024 Dec;
29(1):24-30.
PMID: 39690913
Introduction: Arteriovenous fistula (AVF) maturation failure remains common despite preoperative ultrasound mapping. Identifying predictive biomarkers can help anticipate primary failure and reducing invasive procedures. Our study aimed to identify clinical...
3.
Esteves A, Grilo J, Fragoso P, Pardinhas C, Leal R, Rodrigues L, et al.
Transplant Proc
. 2024 Feb;
56(5):1059-1060.
PMID: 38341296
A kidney transplant is the best option for patients with end-stage renal disease. The waiting list period can be long, especially for highly sensitized patients. We describe a 60-year-old woman...
4.
Duarte R, Castro P, Leal R, Marques M, Rodrigues L, Santos L, et al.
Transplant Proc
. 2023 Jul;
55(6):1390-1395.
PMID: 37429787
Background: Dual and en bloc kidney transplantation are strategies used to mitigate the disparity between a reduced organ pool and an ever-increasing need for organ procurement. En bloc refers to...
5.
Silva R, Leal R, Marques M, Rodrigues L, Santos L, Romaozinho C, et al.
Transplant Proc
. 2023 Jun;
55(6):1400-1403.
PMID: 37295992
Background: For the average patient with end-stage renal disease, kidney transplantation improves quality of life and prolongs survival compared with patients on the transplant waiting list who remain on dialysis....
6.
Silva R, Leal R, Marques M, Rodrigues L, Santos L, Romaozinho C, et al.
Transplant Proc
. 2023 May;
55(6):1396-1399.
PMID: 37202303
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of rapidly progressive glomerulonephritis resulting in end-stage renal disease. The optimal timing of kidney transplantation for end-stage renal disease...
7.
Silva R, Leal R, Marques M, Rodrigues L, Santos L, Romaozinho C, et al.
Exp Clin Transplant
. 2023 Mar;
21(2):171-174.
PMID: 36919725
Antineutrophil cytoplasm antibody-associated systemic vasculitis is a rare disease that frequently leads to end-stage renal disease. Kidney transplant should be delayed until patients are in complete clinical remission for at...
8.
Correia A, Pimenta A, Carias E, Marques M, Leal R, Rodrigues L, et al.
Transplant Proc
. 2022 Jun;
54(5):1278-1281.
PMID: 35768296
Background: Hepatitis E virus (HEV) is a cause of significant morbidity and mortality, representing an important global public health problem. Immunocompetent patients with acute hepatitis E can clear the infection...
9.
Pardinhas C, Leal R, Figueiredo C, Fernandes M, Rodrigues L, Guedes M, et al.
Transplant Proc
. 2022 Jun;
54(5):1236-1241.
PMID: 35643831
Background: Despite progressive improvements in graft and patient survival after kidney transplantation over the last decades, an increasing number of patients are waitlisted for retransplantation. Identifying the risk factors for...
10.
Correia A, Marques M, Leal R, Rodrigues L, Santos L, Romaozinho C, et al.
Transplant Proc
. 2022 May;
54(5):1224-1227.
PMID: 35599204
Background: Living donor kidney transplant represents the best treatment option for patients with end-stage kidney disease; however, it has been associated with possible risks to the donor. Our aim was...